SomaLogic, Inc. Class A Common Stock

SLGC

...

SLGC: SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

Show SLGC Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of SLGC by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by SLGC's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Proteomic assay using quantum sensors Feb. 15, 2022
Patent Title: Lung cancer biomarkers and uses thereof Jan. 11, 2022
Patent Title: Post-selex modification methods Dec. 28, 2021
Patent Title: Method for generating aptamers with improved off-rates Sep. 07, 2021
Patent Title: Pancreatic cancer biomarkers and uses thereof Jun. 22, 2021
Patent Title: Oligonucleotides comprising modified nucleosides Feb. 23, 2021
Patent Title: Nucleic acid compounds for binding growth differentiation factor 11 Oct. 20, 2020
Patent Title: Cardiovascular risk event prediction and uses thereof Jun. 02, 2020
Patent Title: Multiplexed analyses of test samples May. 12, 2020
Patent Title: Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders Jan. 28, 2020
Patent Title: Compositions and methods for detecting microorganisms Jan. 21, 2020
Patent Title: Proteomic assay using quantum sensors Nov. 19, 2019
Patent Title: Multiplexed analyses of test samples Sep. 24, 2019
Patent Title: Tuberculosis biomarkers and uses thereof Sep. 10, 2019
Patent Title: Multiaptamer target detection Aug. 27, 2019
Patent Title: Nucleic acid compounds for binding growth differentiation factor 8 Aug. 06, 2019
Patent Title: Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof Jul. 23, 2019
Patent Title: Lung cancer biomarkers and uses thereof Jul. 23, 2019
Patent Title: Method for generating aptamers with improved off-rates Jun. 11, 2019
Patent Title: Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto Mar. 26, 2019
Patent Title: Post-selec modification methods Mar. 05, 2019
Patent Title: 5-position modified pyrimidines and their use Mar. 05, 2019
Patent Title: Compositions and methods for detecting microorganisms Oct. 09, 2018
Patent Title: Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders Jun. 12, 2018
Patent Title: Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof Apr. 17, 2018
Patent Title: Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto Apr. 10, 2018
Patent Title: Multiaptamer target detection Mar. 27, 2018
Patent Title: Aptamers to pdgf and vegf and their use in treating pdgf and vegf mediated conditions Jul. 11, 2017
Patent Title: Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders Jul. 04, 2017
Patent Title: Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof Apr. 04, 2017
Patent Title: Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof Aug. 23, 2016
Patent Title: Aptamers to pdgf and vegf and their use in treating pdgf and vegf mediated conditions Aug. 09, 2016
Patent Title: Multiplexed analyses of test samples Aug. 02, 2016
Patent Title: Method for generating aptamers with improved off-rates Jul. 05, 2016
Patent Title: Aptamers to 4-1bb and their use in treating diseases and disorders Jun. 14, 2016
Patent Title: Aptamers and diagnostic methods for detecting the egf receptor Apr. 19, 2016
Patent Title: Device and method to accurately and easily assemble glass slides Apr. 19, 2016
Patent Title: Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions Dec. 08, 2015
Patent Title: 5-position modified pyrimidines and their use Oct. 20, 2015
Patent Title: Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof Aug. 11, 2015
Patent Title: Aptamers for clostridium difficile diagnostics Jul. 14, 2015
Patent Title: Method for generating aptamers with improved off-rates Mar. 10, 2015
Patent Title: Method for generating aptamers with improved off-rates Mar. 10, 2015
Patent Title: Multiplexed analyses of test samples Feb. 03, 2015
Patent Title: Device and method to accurately and easily assemble glass slides Jan. 06, 2015
Patent Title: Aptamers for Nov. 25, 2014
Patent Title: Method for purification and identification of sperm cells Apr. 22, 2014
Patent Title: Aptamers to β-ngf and their use in treating β-ngf mediated diseases and disorders Dec. 03, 2013
Patent Title: Selex and photoselex Apr. 02, 2013
Patent Title: Method for generating aptamers with improved off-rates Mar. 26, 2013

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on SLGC's company Twitter account

WallStreetBets

Number of mentions of SLGC in WallStreetBets Daily Discussion

SLGC News

Recent insights relating to SLGC

CNBC Recommendations

Recent picks made for SLGC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SLGC

Corporate Flights

Flights by private jets registered to SLGC